Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christelle Ziller"'
Autor:
Jean-Baptiste Marchand, Monika Semmrich, Christelle Ziller, Matilda Rehn, Laetitia Fend, Petra Holmkvist, Nathalie Silvestre, Carolin Svensson, Kleinpeter Patricia, Jules Deforges, Fred Junghus, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Björn Frendéus, Eric Quéméneur
Publikováno v:
Cancer Research. 82:3567-3567
Background Immune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of cancer patients including those with poorly immune infiltrated “cold” tumors are resistant to currently available ICB therapies. Onco
Publikováno v:
Cancer Immunology, Immunotherapy. 54:548-556
Efforts to follow tumor-specific immune responses in patients are often thwarted by lack of knowledge of the appropriate tumor antigens and the CTL epitopes of those antigens. There is, therefore, a growing need for techniques to monitor tumor-specif
Autor:
Hubert Lincet, Christelle Ziller, Jean-Paul Behr, Christian D. Muller, Laurent Poulain, Cathy Staedel
Publikováno v:
Cancer Letters. 212:43-52
Suicide gene therapy could be an attractive addition to the treatment of ovarian carcinomas, for which acquired chemoresistance frequently results in treatment failure. Here we show that transfection of the HSV-tk gene, followed by incubation with up
Autor:
Jean-Paul Behr, Patrick Erbacher, Christelle Ziller, Jean-François Rodier, Christian D. Muller, Thierry Bettinger, Laurent Poulain
Publikováno v:
Cancer Gene Therapy. 7:644-652
As a prerequisite to nonviral gene therapy approaches of ovarian carcinoma, we evaluated the possibility of transfecting established tumor cell lines (SKOV3, IGROV1) as well as primary mesothelial and tumor cells by various polyethylenimine (PEI) der
Autor:
Benoît Grellier, Ronald Rooke, Thierry Menguy, Sandrine Cochin, Jean-Baptiste Marchand, Christine Thioudellet, Michel Geist, Jean-Yves Bonnefoy, Vanessa Duong, Carine Reymann, Hélène Haegel, Xavier Préville, Rémy Hallet, Christelle Ziller-Remy, Luc Barraud
Publikováno v:
Cancer Research. 75:288-288
Cancer progression has been associated with the presence of tumor-associated M2-type macrophages (M2-TAMs) able to inhibit anti-tumor immune responses, stimulate neo-angiogenesis and facilitate metastasis. Colony-stimulating factor-1 (CSF-1, M-CSF) i